Home » Toolkits » New Product

New Product

Implementing Pathogen Inactivated Platelets

Here’s one hospital’s experience with implementing the new pathogen reduced pooled platelet component

February 13, 2023

Introducing a New Blood Component or Product to Your Hospital

The purpose of developing this toolkit is to facilitate the introduction of new blood products is to support Ontario hospitals in the transition of making new blood products available within their organizations. This toolkit includes checklists and suggestions to assist in the examination of key aspects prior to implementation, during implementation and afterwards. Revised 2018.

Appendix 1: A. Pre-Implementation Tasks

What We Need to Know Before a New Blood Product is Introduced. Revised 2018.

Appendix 2: B. New Blood Product Planning Tasks

What We Should Do Before a New Blood Product is Introduced. Revised 2018.

Appendix 3: C. Post-Implementation Tasks

What We Need to Do After a New Blood Product is Introduced. Revised 2018.

Appendix 4: Blood Product Administration Guidelines (Monographs)-CSP

Revised 2018.

Appendix 5: Blood Component or Product Administration Guidelines (Monographs)-Fibrinogen

Revised 2018.